AMANDA DAVIS: Open Payments
NPI 1619413275 · HELENA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,760 in 83 payments from 19 companies in 2025. Trend: 2023 $1,741 · 2024 $2,356 · 2025 $1,760
Food & beverage: $1,760
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 13 | $288 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $250 |
| Madrigal Pharmaceuticals | 6 | $165 |
| Phathom Pharmaceuticals, Inc. | 11 | $164 |
| GENZYME CORPORATION | 6 | $137 |
| QOL Medical, LLC | 5 | $129 |
| Janssen Biotech, Inc. | 1 | $121 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $112 |
| Lilly USA, LLC | 4 | $77 |
| Aimmune Therapeutics, Inc. | 5 | $69 |
Products named: IBSRELA, ENTYVIO, DUPIXENT, REZDIFFRA, VOQUEZNA, Sucraid, TREMFYA, XIFAXAN.
Industry payments across AL — which companies pay providers there.
